Novartis CEO Vasella accuses "Tagesschau" of distorting statements
Novartis CEO Daniel Vasella criticizes the way in which he was quoted on Swiss television's "Tagesschau" last week. His statements were falsified. Swiss television does not accept Vasella's criticism.
Novartis CEO Daniel Vasella has criticized the way he was quoted on Swiss television's "Tagesschau" last week. At the time, he said that the discussion about bonus payments was "pure populism". In an interview in the NZZ am Sonntag, Vasella said that it was easy to distort statements by deliberately reproducing only certain sections of a conversation. He had not defended the bonus structure of the banks, but merely the logic of performance-oriented salary systems.
"I dislike the hypocrisy and populism of certain circles," Vasella continued. However, he does not understand populism to be the population's reaction to very high wages, but rather when these emotions are exploited against their better judgment, for example for political purposes.
Swiss television does not accept Vasella's criticism. "From our point of view, the interview was reproduced correctly," media spokesman David Affeltranger told the news agency SDA.
In an interview with the NZZ am Sonntag, Vasella also reiterated his earlier statement that the pharmaceutical company Novartis would not change its remuneration system. "If you start making changes just because the political environment changes, our employees would not be able to understand that." Besides, Novartis is not in crisis.
"I dislike the hypocrisy and populism of certain circles," Vasella continued. However, he does not understand populism to be the population's reaction to very high wages, but rather when these emotions are exploited against their better judgment, for example for political purposes.
Swiss television does not accept Vasella's criticism. "From our point of view, the interview was reproduced correctly," media spokesman David Affeltranger told the news agency SDA.
In an interview with the NZZ am Sonntag, Vasella also reiterated his earlier statement that the pharmaceutical company Novartis would not change its remuneration system. "If you start making changes just because the political environment changes, our employees would not be able to understand that." Besides, Novartis is not in crisis.
